Demographic, clinical, and pathological characteristics of Turkish triple-negative breast cancer patients: Single center experience [2]

Annals of Oncology

Volumn 18, Issue 11, 2007, Pages 1904-1906

  Aksoy, S ^a   Dizdar, O ^a   Harputluoglu, H ^a   Altundag, K ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HORMONE; ORAL CONTRACEPTIVE AGENT; PEROXIDASE; PROGESTERONE RECEPTOR;

ADJUVANT THERAPY; BREAST CANCER; CANCER GRADING; CANCER HORMONE THERAPY; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; FAMILY HISTORY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREMENOPAUSE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; TURKEY (REPUBLIC);

ADULT; AGE DISTRIBUTION; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; PROBABILITY; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK ASSESSMENT; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TURKEY;

EID: 36148977228     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm487     Document Type: Letter

References (9)

1. Perou CM, Sorlie T, Eisen MB et al. Molecular portraits of human breast tumours. Nature 2000; 406: 747-752.
2. Sorlie T, Perou CM, Tibshirani R. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001; 98: 10869-10874.
3. Cleator S, Heller W, Coombes RC. Triple-negative breast cancer: therapeutic options, Lancet Oncol 2007; 8: 235-244.
4. Carey LA, Perou CM, Livasy CA et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006; 295: 2492-2502.
5. Millikan RC, Newman B, Tse CK et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 2007 Jun 20; [Epub ahead of print].
6. Yang XR, Sherman ME, Rimm DL et al. Dffferences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev 2007; 16: 439-443.
7. Silva LD, Clarke C, Lakhani SR. Basal-like breast cancer. J Clin Pathol 2007 May 11; [Epub ahead of print].
8. Foulkes WD, Metcalfe K, Hanna W et al. Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma. Cancer 2003; 98: 1569-1577.
9. Rodriguez-Pinilla SM, Sarrio D, Honrado E et al. Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas. Clin Cancer Res 2006; 12: 1533-1539.